| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/18/1995 | CN1097420A Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes |
| 01/18/1995 | CN1097417A 新的杂环化合物 New heterocyclic compounds |
| 01/18/1995 | CN1097416A Novel beta-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes |
| 01/17/1995 | US5382675 Polycyclic compounds and processes for the preparation thereof |
| 01/17/1995 | US5382597 Organo-tin compounds having anti-tumour activity and anti-tumour compositions |
| 01/17/1995 | US5382581 Anticarcinogenic agents or antitumor agents |
| 01/17/1995 | US5382569 Hexapeptides for cardiovascular disorders |
| 01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
| 01/17/1995 | US5382427 Use of IL-4 to treat solid tumors |
| 01/17/1995 | CA2128175A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 01/17/1995 | CA2128139A1 Mdr reversal agents |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001433A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 01/12/1995 | WO1995001376A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/12/1995 | WO1995001374A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001364A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 01/12/1995 | WO1995001349A1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
| 01/12/1995 | WO1995001348A2 Imides as inhibitors of tnp alpha |
| 01/12/1995 | WO1995001342A1 Ansamycin derivatives as antioncogene and anticancer agents |
| 01/12/1995 | CA2626178A1 Process for the preparation of thalidomide |
| 01/12/1995 | CA2531868A1 Process for the preparation of thalidomide |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166333A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | CA2166320A1 Ansamycin derivatives as antioncogene and anticancer agents |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2142713A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/12/1995 | CA2142472A1 Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
| 01/11/1995 | EP0633247A1 2-Bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof |
| 01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
| 01/11/1995 | EP0632805A1 Melamine derivatives for use in the treatment of cancer |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 01/11/1995 | EP0301034B1 Use of 1-(3'trifluoromethyl 4'-nitrophenyl) 4,4-dimethyl imidazoline 2, 5-dione in the manufacture of a medicament for the treatment of hormone-dependent cancers other than cancers of the prostate, the skin and the colon |
| 01/11/1995 | EP0207090B1 Monoclonal antibodies and antigens for human non-small cell lung carcinomas |
| 01/10/1995 | US5380897 Tri(platinum) complexes |
| 01/10/1995 | US5380879 Immunosuppressants |
| 01/10/1995 | US5380759 Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia |
| 01/10/1995 | US5380751 6,7-modified paclitaxels |
| 01/10/1995 | US5380750 Arylethylamine compounds |
| 01/10/1995 | US5380749 Thioxanthenone antitumor agents |
| 01/10/1995 | US5380736 Cholecystokinin and gastric antagonist |
| 01/10/1995 | US5380513 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 01/10/1995 | US5380411 Ultrasound or shock wave work process and preparation for carrying out same |
| 01/10/1995 | EP0639186A4 Taxol derivatives. |
| 01/10/1995 | CA1333887C Immunity memory cell suspension and method of preparing same |
| 01/05/1995 | WO1995000654A1 Mesothelial cell gene therapy |
| 01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
| 01/05/1995 | WO1995000515A1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000497A1 Inhibitors of farnesyl-protein transferase |
| 01/05/1995 | WO1995000490A1 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 01/05/1995 | WO1995000169A1 Medical use of stem bromelain protease |
| 01/05/1995 | WO1995000159A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2165787A1 Medical use of stem bromelain protease |
| 01/05/1995 | CA2165765A1 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2165176A1 Inhibitors of farnesyl-protein transferase |
| 01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | CA2161436A1 Antiproliferative naphthyridines |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632053A2 Cyclic adhesion inhibitors |
| 01/04/1995 | EP0632042A1 Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6 |
| 01/04/1995 | EP0631784A1 Sulphated polysaccharides having anti-inflammatory activity |
| 01/04/1995 | EP0631576A1 Dipeptidylquinazolones as anti-cancer agents |
| 01/04/1995 | EP0631570A1 Compounds |
| 01/04/1995 | EP0631474A1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use |
| 01/04/1995 | EP0567576B1 Treatment of neoplastic disease with interleukin-10 |
| 01/04/1995 | CN1097005A Chemical compounds |
| 01/04/1995 | CN1027267C Method for preparing of N-acyl derivatives of LL-E33288 antitumor antibiotics |
| 01/04/1995 | CN1027265C Process for preparing of water-soluble camptothecin analogues |
| 01/03/1995 | US5378835 Water solubile salt from pheophorbide and sodium hydroxide |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378725 Administering as antitumor or anticarcinogenic agent to mammals |
| 01/03/1995 | US5378721 Aromatase inhibitors |
| 01/03/1995 | US5378710 17β-substituted aza-androstane derivatives |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378463 Bactericide, biosynthesis |
| 01/03/1995 | US5378456 Antitumor mitoxantrone polymeric compositions |
| 12/28/1994 | EP0630905A1 Process for selectively isolating bêta-2'-deoxy-2',2'-difluorocytidine or its salts |
| 12/28/1994 | EP0630412A1 Methods to profile and treat abnormal cells |
| 12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 12/28/1994 | EP0617705A4 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them. |
| 12/28/1994 | CN1027169C Method for preparation of epiodophylltoxin glucoside 4'-phosphate |
| 12/27/1994 | US5376669 Antitumor agents |
| 12/27/1994 | US5376653 A protease enzyme inhibitor for treating degenerative diseases , respiratory system disorders, rheumatoid arthritis and pancreatitis |
| 12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029444A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
| 12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
| 12/22/1994 | WO1994029350A2 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 12/22/1994 | WO1994029344A1 Super proteins including interferons and interleukins |
| 12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
| 12/22/1994 | WO1994029318A1 Cephalostatin analogues and their use as anti-tumour agents |
| 12/22/1994 | WO1994029312A1 O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells |